News & Insights | Clinical Insider

This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Patient centricity, market access, and private equity fueled CRO M&A in 2024

Private equity firm sets out expansion plan for EMAS Pharma

Carta Healthcare buys trial data abstraction counterpart Realyze Intelligence

hVIVO contracted for $11.5m Phase IIb RSV antiviral trial

Swiss authorities clarify safety rules for first-in-human trials

Unlearn to use APST data to develop digital twin models for ALS trials

UK aims to simplify consent rules for low risk clinical trials

AstraZeneca opts for adaptive trial for brain cancer drug candidate

UK and Australian governments team to support platform studies

1MED buys Italian CRO LB Research to build in Southern Europe

Abbott urges CROs, sponsors to increase trial diversity

AI tech TrialGPT can cut screening time by 40%, says NIH

Patient centricity will change the CRO space, according to new research

Novotech to support Beijing Biostar’s clinical R&D efforts

Frontage teams with Medicover for genomics services

Sanofi to use AI to accelerate recruitment in Phase III MS program

Trial software space an investment opportunity, new analysis says

Vidac hires Forschungsdock CRO for Phase IIb study of novel skin cancer drug

Ontario government commits C$5m to accelerated study start program

Icon cuts forecast, mulls staff changes after Q3 revenue slides

Quick Links